Sign in

CIK 0000818033 · Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
942875566
Phone
8582514400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-04-13 MANHARD KIMBERLY EVP, Drug Development Option exercise · Restricted Stock Units −1,250 7,500
2023-04-13 MANHARD KIMBERLY EVP, Drug Development Option exercise · Restricted Stock Units −4,564 27,936
2023-04-03 Collard Craig A Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +3,000,000 3,000,000
2023-04-03 Collard Craig A Chief Executive Officer Grant or award · Restricted Stock Units +250,000 250,000
2023-04-03 Collard Craig A Chief Executive Officer Grant or award · Employee Performance Stock Option (Right to Buy) +4,250,000 4,250,000
2023-02-22 Morgan Adam Director Grant or award +37,879 37,879
2023-02-22 Morgan Adam Director Grant or award · Stock Option (Right to Buy) +227,272 227,272
2023-01-18 Szekeres David Leslie EVP, Chief Operating Officer Grant or award · Performance Stock Units +49,788 49,788
2023-01-18 Quart Barry D Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +850,000 850,000
2023-01-18 POYHONEN JOHN President & CCO Grant or award · Performance Stock Units +66,385 66,385
2023-01-18 Peraza Lisa VP, Chief Accounting Officer Grant or award · Performance Stock Units +42,631 42,631
2023-01-18 MANHARD KIMBERLY EVP, Drug Development Grant or award · Performance Stock Units +149,365 149,365
2023-01-13 Szekeres David Leslie EVP, Chief Operating Officer Option exercise +1,250 23,598
2023-01-13 Szekeres David Leslie EVP, Chief Operating Officer Option exercise +4,564 28,162
2023-01-13 Szekeres David Leslie EVP, Chief Operating Officer Shares withheld for taxes −2,012 $3.17 $6K 26,150
2023-01-13 Szekeres David Leslie EVP, Chief Operating Officer Option exercise · Restricted Stock Units −1,250 8,750
2023-01-13 Szekeres David Leslie EVP, Chief Operating Officer Option exercise · Restricted Stock Units −4,564 32,500
2023-01-13 Quart Barry D Chief Executive Officer Option exercise +3,645 167,086
2023-01-13 Quart Barry D Chief Executive Officer Option exercise +16,122 183,208
2023-01-13 Quart Barry D Chief Executive Officer Shares withheld for taxes −5,219 $3.17 $17K 177,989

Page 16 of 28 · 557 trades